Skip to main content
SpringerLink
Log in

Effects of Acute Febrile Infectious Diseases on the Oral Pharmacokinetics and Effects of Nitrendipine Enantiomers and of Bisoprolol

  • Original Research Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

In 2 longitudinal studies with 10 patients each, the stereoselective pharmacokinetics of nitrendipine and the pharmacokinetics of racemic (rac) bisoprolol (both 20mg orally) were investigated during acute febrile infectious diseases and at least 6 weeks later in the healthy state.

The area under the plasma concentration-time curve (AUC) and peak plasma concentration (Cmax) of rac-nitrendipine were increased in the infectious state by 89% [95% confidence interval (CI): 24 to 187%] and 95% (95% CI: 22 to 209%), respectively. Similar increases were observed for both S- and R-nitrendipine. Nitrendipine exhibited stereoselective pharmacokinetics in both the healthy state and the infectious state, but the mean ratios of S: R AUC values [healthy: 1.79 (95% CI: 1.36 to 2.11); infectious: 1.87 (95% CI: 1.62 to 2.11)] were not different. The elimination half-life, protein binding and haemodynamic effects of nitrendipine also did not differ between the infectious and the healthy state. The mechanism for the disease effects may be related to suppression of hepatic cytochrome P450 activity by mediators of inflammatory reactions.

On the other hand, none of the pharmacokinetic parameters, including nonrenal clearance, of rac-bisoprolol was changed during febrile infectious disease, indicating specificity in the effects of acute febrile disease on oxidative drug metabolism.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Avery GS, Heel RC. Guide to the clinically more important drug interactions. In Avery GS. (Ed) Drug treatment: principles and practice of clinical pharmacology and therapeutics, 2nd ed., pp. 1252–1272, ADIS Press, Sydney, 1980

    Google Scholar 

  • Batra JK, Venkitsubramanian TA, Raj HG. Drug metabolism in experimental tuberculosis I: changes in hepatic and pulmonary monooxygenase activities due to infection. European Journal of Drug Metabolism and Pharmacokinetics 12: 109–114, 1987

    Article  PubMed  CAS  Google Scholar 

  • Beck FJ, Whitehouse MW. Impaired drug metabolism in rats associated with acute inflammation: a possible assay for anti-injury agents. Proceedings of the Society for Experimental Biology and Medicine 145: 135–140, 1974

    PubMed  CAS  Google Scholar 

  • Blumenkopf B, Lockhart WS. Herpes zoster infection and use of oral anticoagulants: a potentially dangerous association. Journal of the American Medical Association 250: 936–937, 1983

    Article  PubMed  CAS  Google Scholar 

  • Böcker RH, Preuss E, Peter R. High-performance liquid chromatography of the metabolites of nitrendipine and investigation into the metabolic pathways of this dihydropyridine. Journal of Chromatography 530: 206–211, 1990

    Article  PubMed  Google Scholar 

  • Borgå O, Odar-Cederlöf I, Piafsky KM, Sjöqvist F. Plasma protein binding of propranolol in disease states. British Journal of Clinical Pharmacology 4: 627–628, 1977

    Article  Google Scholar 

  • Bradley SE. Variations in hepatic blood flow in man during health and disease. New England Journal of Medicine 240: 456–461, 1949

    Article  PubMed  CAS  Google Scholar 

  • Brian WR, Sari MA, Iwasaka M, Shimada T, Kaminsky LS, et al. Catalytic activities of human liver cytochrome P-450 IIIA4 expressed in Saccharomyces cereviciae. Biochemistry 29: 11280–11292, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bühring KU, Garbe A. Determination of the new β-blocker bisoprolol and of metoprolol, atenolol and propranolol in plasma and urine by high-performance liquid chromatography. Journal of Chromatography 382: 215–224, 1986

    Article  PubMed  Google Scholar 

  • Bühring KU, Sailer H, Faro HP, Leopold G, Pabst J, et al. Pharmacokinetics and metabolism of bisoprolol-14C in three animal species and in humans. Journal of Cardiovascular Pharmacology 8 (Suppl. 11): 21–28, 1986

    Google Scholar 

  • Craig L, Mehta I, Murray M, McDonald D, Åstrom A, et al. Interferon down-regulates the male-specific cytochrome P-450 IIIA2 in rat liver. In Ingelman-Sundberg et al. (Eds) Drug metabolizing enzymes: genetics, regulation and toxicology, p. 63, Karolinska Institutet, Stockholm, 1990

    Google Scholar 

  • Descotes J. Immunomodulating agents and hepatic drug-metabolizing enzymes. Drug Metabolism Reviews 16: 175–184, 1985

    Article  PubMed  CAS  Google Scholar 

  • Endo Y, Tsuriya S, Fujihira E. Hepatic drug-metabolizing enzyme activities and anti-inflammatory potency of hydrocortisone in rats with granulomatous inflammation. Research Communications in Chemical Pathology and Pharmacology 33: 195–206, 1981

    PubMed  CAS  Google Scholar 

  • Farrell GC. Drug metabolism in extrahepatic diseases. Pharmacology and Therapeutics 35: 375–404, 1987

    Article  PubMed  CAS  Google Scholar 

  • Ghezzi P, Saccardo B, Villa P, Rossi V, Bianchi M, et al. Role of interleukin-1 in the depression of liver drug metabolism by endotoxin. Infection and Immunity 54: 837–840, 1986

    PubMed  CAS  Google Scholar 

  • Guengerich FP, Böcker RH. Cytochrome P-450-catalyzed dehydrogenation of 1,4-dihydropyridines. Journal of Biological Chemistry 263: 8168–8175, 1988

    PubMed  CAS  Google Scholar 

  • Kendall MJ, Quarterman CP, Bishop H, Schneider RE. Effects of inflammatory disease on plasma oxprenolol concentrations. British Medical Journal 278: 465–468, 1979

    Article  Google Scholar 

  • Kirch W, Rose I, Demers HG, Leopold G, Pabst J, et al. Pharmacokinetics of bisoprolol during repeated oral administration to healthy volunteers and patients with kidney or liver disease. Clinical Pharmacokinetics 13: 110–117, 1987

    Article  PubMed  CAS  Google Scholar 

  • Kirch W, Rose I, Klingmann I, Pabst J, Ohnhaus EE. Interaction of bisoprolol with cimetidine and rifampicin. European Journal of Clinical Pharmacology 31: 59–62, 1986

    Article  PubMed  CAS  Google Scholar 

  • Kirch W, Spahn H, Ohnhaus EE, Köhler H, Heinz U, et al. Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprolol. Biopharmaceutics and Drug Disposition 4: 73–81, 1983

    Article  CAS  Google Scholar 

  • Kubicek WG, Patterson RP, Witsoe DA. Impedance cardiography as an non-invasive method of monitoring cardiac function and other parameters of the cardiovascular system. Annals of the New York Academy of Sciences 170: 724–728, 1970

    Article  Google Scholar 

  • Leopold G. Balanced pharmacokinetics and metabolism of bisoprolol. Journal of Cardiovascular Pharmacology 8 (Suppl. 11): 16–20, 1986

    Google Scholar 

  • Leopold G, Pabst J, Ungethüm W, Bühring KU. Basic pharmacokinetics of bisoprolol, a new highly beta1-selective adrenoreceptor antagonist. Journal of Clinical Pharmacology 26: 616–621, 1986

    PubMed  CAS  Google Scholar 

  • Levine M, Jones MW. Toxic reaction to phenytoin following a viral infection. Canadian Medical Association Journal 128: 1270–1271, 1983

    PubMed  CAS  Google Scholar 

  • Lipton A, Hepner GW, White DS, Harvey HA. Decreased hepatic drug demethylation in patients receiving chemo-immunotherapy. Cancer 41: 1680–1684, 1978

    Article  PubMed  CAS  Google Scholar 

  • Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, et al. Effects of influenza virus vaccine on hepatic drug metabolism. Clinical Pharmacology and Therapeutics 37: 396–401, 1985

    Article  PubMed  CAS  Google Scholar 

  • Mikus G, Fischer C, Heuer B, Langen C, Eichelbaum M. Application of stable isotope methodology to study the pharmacokinetics, bioavailability and metabolism of nitrendipine after i.v. and p.o. administration. British Journal of Clinical Pharmacology 24: 561–569, 1987

    Article  PubMed  CAS  Google Scholar 

  • Moochhala SM, Renton KW. Induction and depression of cytochrome P-450-dependent mixed-function oxidase by a cloned consensus αInterferon (INF-αCON1) in the hamster. Biochemical Pharmacology 38: 439–447, 1989

    Article  PubMed  CAS  Google Scholar 

  • Morgan ET. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Molecular Pharmacology 36: 699–707, 1989

    PubMed  CAS  Google Scholar 

  • Okuno H, Kitao Y, Takasu M, Kunieda K, Seki T, et al. Depression of drug metabolizing activity in the human liver by interferon-α. European Journal of Clinical Pharmacology 39: 365–367, 1990

    Article  PubMed  CAS  Google Scholar 

  • Rämsch KD, Graefe KH, Scherling D, Sommer J, Ziegler R. Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine and nimodipine. American Journal of Nephrology 6 (Suppl. 1): 73–80, 1986

    PubMed  Google Scholar 

  • Renton KW. The deleterious effect of Bordetella pertussis vaccine and poly(rI·rC) on the metabolism and disposition of phenytoin. Journal of Pharmacology and Experimental Therapeutics 208: 267–270, 1979

    PubMed  CAS  Google Scholar 

  • Schneider RE, Bishop H, Hawkins CF. Plasma propranolol concentrations and the erythrocyte sedimentation rate. British Journal of Clinical Pharmacology 8: 43–47, 1979

    Article  PubMed  CAS  Google Scholar 

  • Singh G, Renton KW. Interferon-mediated depression of cytochrome P-450-dependent drug biotransformation. Molecular Pharmacology 20: 681–684, 1981

    PubMed  CAS  Google Scholar 

  • Soons PA, Breimer DD. Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjects. British Journal of Clinical Pharmacology 32, 11–16, 1991

    Article  PubMed  CAS  Google Scholar 

  • Soons PA, Cohen Af, Breimer DD. Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects: concentration-effect relationships of racemic drugs and enantiomers European Journal of Clinical Pharmacology, in press, 1992

    Google Scholar 

  • Soons PA, de Boer AG, van Brummelen P, Breimer DD. Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study. British Journal of Clinical Pharmacology 27: 179–189, 1989

    Article  PubMed  CAS  Google Scholar 

  • Soons PA, Roosemalen MCM, Breimer DD. Enantioselective determination of felodipine and other chiral dihydropyridine calcium entry blockers in human plasma. Journal of Chromatography 528: 343–356, 1990

    Article  PubMed  CAS  Google Scholar 

  • Soons PA, Schellens JHM, Breimer DD. Variability in pharmacokinetics and metabolism of nifedipine and other dihydropyridine calcium entry blockers. In Kalow W (Ed.) Pharmacogenetics of drug metabolism, pp. 769–789, Pergamon Press, New York, 1992

    Google Scholar 

  • Trenholme GM, Williams RL, Rieckmann KH, Frischer H, Carson PE. Quinine disposition during malaria and during induced fever. Clinical Pharmacology and Therapeutics 19: 459–467, 1976

    PubMed  CAS  Google Scholar 

  • Weissler AM, Harris WS, Schoenfeld CD. Systolic time intervals in heart failure in man. Circulation 37: 149–157, 1968

    Article  PubMed  CAS  Google Scholar 

  • Wellstein A, Palm D, Belz GG, Leopold G, Bühring KU, et al. Concentration kinetics of propranolol, bisoprolol and atenolol in humans assessed with chemical detection and a subtype-selective β-adrenoreceptor assay. Journal of Cardiovascular Pharmacology 8 (Suppl. 11): 41–45, 1986

    Google Scholar 

  • Williams SJ, Baird-Lambert J, Cantrill EM, Farrell GC. Interferon inhibits hepatic clearance of theophylline by a noncompetitive mechanism. Australian and New Zealand Journal of Medicine 17: 128, 1987

    Article  Google Scholar 

  • Williams SJ, Farrell GC. Inhibition of antipyrine metabolism by interferon. British Journal of Clinical Pharmacology 22: 610–612, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pharmacology, Center for Bio-Pharmaceutical Sciences, Leiden University, Leiden, The Netherlands

    Paul A. Soons, Catarina Grib, Douwe D. Breimer &  Wilhelm Kirch

  2. Department of Internal Medicine, Christian-Albrechts University, Schittenhelmstrasse 12, 2300, Kiel 1, Federal Republic of Germany

    Paul A. Soons, Catarina Grib, Douwe D. Breimer &  Wilhelm Kirch

Authors
  1. Paul A. Soons
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Catarina Grib
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Douwe D. Breimer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wilhelm Kirch
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Soons, P.A., Grib, C., Breimer, D.D. et al. Effects of Acute Febrile Infectious Diseases on the Oral Pharmacokinetics and Effects of Nitrendipine Enantiomers and of Bisoprolol. Clin. Pharmacokinet. 23, 238–248 (1992). https://doi.org/10.2165/00003088-199223030-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-199223030-00006

Keywords

Search

Navigation